InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Results of Operations and Financial Condition

0

InfuSystem Holdings, Inc. (NYSEMKT:INFU) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition

On October31, 2017, InfuSystem Holdings, Inc. issued a press release announcing that the Company will disclose its financial results for the third quarter ended September30, 2017 on Friday, November10, 2017 before the market opens. The Company will also conduct a conference call for all interested investors on Friday, November10, 2017, at 11:00 a.m. Eastern Time. A copy of the press release is furnished as an exhibit to this Form 8-K.

Item 2.02. Financial Statements and Exhibits

(a) Financial statements:

None

(b) Pro forma financial information:

None

(c) Shell company transactions:

None

(d) Exhibits

99.1

Press Release of InfuSystem Holdings, Inc. dated October31, 2017.

Index to Exhibits


InfuSystem Holdings, Inc Exhibit
EX-99.1 2 d472493dex991.htm EX-99.1 EX-99.1 Exhibit 99.1              InfuSystem Holdings,…
To view the full exhibit click here

About InfuSystem Holdings, Inc. (NYSEMKT:INFU)

InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.